Cholesteryl Ester Transfer Protein, Coronary Calcium, and Intima-Media Thickness of the Carotid Artery in Middle-Age Japanese Men

American Journal of Cardiology

Volumn 104, Issue 6, 2009, Pages 818-822

  Okamura, Tomonori ^a,b   Sekikawa, Akira ^c   Kadowaki, Takashi ^b   El Saed, Aiman ^c   Abbott, Robert D ^d   Curb, J David ^e   Edmundowicz, Daniel ^c   Nakamura, Yasuyuki ^f   Murata, Kiyoshi ^b   Kashiwagi, Atsunori ^b   Sutton Tyrrell, Kim ^c   Evans, Rhobert W ^c   Zmuda, Joseph M ^c   Maegawa, Hiroshi ^b   Hozawa, Atsushi ^b   Mitsunami, Ken Ichi ^b   Nishio, Yoshihiko ^b   Miljkovic Gacic, Iva ^c   Horie, Minoru ^b   Miyamatsu, Naomi ^b   Murakami, Yoshitaka ^b   Kuller, Lewis H ^c   Ueshima, Hirotsugu ^b   more..

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLESTEROL ESTER TRANSFER PROTEIN;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CETP D442G GENE; CORONARY ARTERY; GENE; GENETIC VARIABILITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE;

ADULT; CALCIUM; CAROTID ARTERIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TUNICA INTIMA; TUNICA MEDIA;

EID: 69449092110     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.021     Document Type: Article

References (29)

1. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res 34 (1993) 1255-1274
2. Rumana N., Kita Y., Turin T.C., Murakami Y., Sugihara H., Morita Y., Tomioka N., Okayama A., Nakamura Y., and Ueshima H. Seasonal pattern of incidence and case fatality of acute myocardial infarction in a Japanese population (from the Takashima AMI Registry, 1988-2003). Am J Cardiol 102 (2008) 1307-1311
3. Okamura T., Kokubo Y., Watanabe M., Higashiyama A., Miyamoto Y., Yoshimasa Y., and Okayama A. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: the Suita study. Atherosclerosis 203 (2009) 587-592
4. Inazu A., Jiang X.C., Haraki T., Yagi K., Kamon N., Koizumi J., Mabuchi H., Takeda R., Takata K., Moriyama Y., and Doi M. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94 (1994) 1872-1882
5. Sekikawa A., Ueshima H., Kadowaki T., El-Saed A., Okamura T., Takamiya T., Kashiwagi A., Edmundowicz D., Murata K., Sutton-Tyrrell K., Maegawa H., Evans R.W., Kita Y., and Kuller L.H. Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-World War II birth cohort. Am J Epidemiol 165 (2007) 617-624
6. Okamura T., Kadowaki T., Sekikawa A., Murata K., Miyamatsu N., Nakamura Y., El-Saed A., Kashiwagi A., Maegawa H., Nishio Y., Takamiya T., Kanda H., Mitsunami K., Kita Y., Edmundowicz D., Tamaki S., Tsujita Y., Kuller L.H., and Ueshima H. Alcohol consumption and coronary artery calcium in middle-aged Japanese men. Am J Cardiol 98 (2006) 141-144
7. Nakamura Y., Ueno Y., Tamaki S., Kadowaki T., Okamura T., Kita Y., Miyamatsu N., Sekikawa A., Takamiya T., El-Saed A., Sutton-Tyrrell K., and Ueshima H. Fish consumption and early atherosclerosis in middle-aged men. Metabolism 56 (2007) 1060-1064
8. Sekikawa A., Curb J.D., Ueshima H., El-Saed A., Kadowaki T., Abbott R.D., Evans R.W., Rodriguez B.L., Okamura T., Sutton-Tyrrell K., Nakamura Y., Masaki K., Edmundowicz D., Kashiwagi A., Willcox B.J., Takamiya T., Mitsunami K., Seto T.B., Murata K., White R.L., Kuller L.H., ERA JUMP (Electron-Beam Tomography, and Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese Americans, and whites: a cross-sectional study. J Am Coll Cardiol 52 (2008) 417-424
9. Sasai K., Okumura-Noji K., Hibino T., Ikeuchi R., Sakuma N., Fujinami T., and Yokoyama S. Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients. Clin Chem 44 (1998) 1466-1473
10. Kokubo Y., Okamura T., Yoshimasa Y., Miyamoto Y., Kawanishi K., Kotani Y., Okayama A., and Tomoike H. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the Suita study. Hypertens Res 31 (2008) 2027-2035
11. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
12. Thompson T., Sutton-Tyrrell K., and Wildman R. Continuous quality assessment programs can improve carotid duplex scan quality. J vasc Technol 25 (2001) 33-39
13. Barter P.J., Brewer Jr. H.B., Chapman M.J., Hennekens C.H., Rader D.J., and Tall A.R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 23 (2003) 160-167
14. Hirano K., Yamashita S., Nakajima N., Arai T., Maruyama T., Yoshida Y., Ishigami M., Sakai N., Kameda-Takemura K., and Matsuzawa Y. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 17 (1997) 1053-1059
15. Boekholdt S.M., Kuivenhoven J.A., Wareham N.J., Peters R.J., Jukema J.W., Luben R., Bingham S.A., Day N.E., Kastelein J.J., and Khaw K.T. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study. Circulation 110 (2004) 1418-1423
16. Föger B., Luef G., Ritsch A., Schmidauer C., Doblinger A., Lechleitner M., Aichner F., and Patsch J.R. Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness. J Mol Med 73 (1995) 369-372
17. Zhuang Y., Wang J., Qiang H., Li Y., Lui X., Li L., and Chen G. Serum cholesteryl ester transfer protein concentrations in healthy Chinese subjects and cardio-cerebrovascular disease patients. Clinica Chim Acta 305 (2001) 19-25
18. Klerkx A.H., de Grooth G.J., Zwinderman A.H., Jukema J.W., Kuivenhoven J.A., and Kastelein J.J. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS). Eur J Clin Invest 34 (2004) 21-28
19. Colhoun H.M., Scheek L.M., Rubens M.B., Van Gent T., Underwood S.R., Fuller J.H., and Van Tol A. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 50 (2001) 652-659
20. de Vries R., Perton F.G., Dallinga-Thie G.M., van Roon A.M., Wolffenbuttel B.H., van Tol A., and Dullaart R.P. Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes 54 (2005) 3554-2559
21. Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J., Komajda M., Lopez-Sendon J., Mosca L., Tardif J.C., Waters D.D., Shear C.L., Revkin J.H., Buhr K.A., Fisher M.R., Tall A.R.B.B., and ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357 (2007) 2109-2122
22. Nissen S.E., Tardif J.C., Nicholls S.J., Revkin J.H., Shear C.L., Duggan W.T., Ruzyllo W., Bachinsky W.B., Lasala G.P.T.E.M., and ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 356 (2007) 1304-1316
23. Bots M.L., Visseren F.L., Evans G.W., Riley W.A., Revkin J.H., Tegeler C.H., Shear C.L., Duggan W.T., Vicari R.M., Grobbee D.E.K.J.J., and RADIANCE 2 Investigators. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 370 (2007) 153-160
24. Vergeer M., Bots M.L., van Leuven S.I., Basart D.C., Sijbrands E.J., Evans G.W., Grobbee D.E., Visseren F.L., Stalenhoef A.F., Stroes E.S., and Kastelein J.J. Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials. Circulation 118 (2008) 2515-2522
25. Curb J.D., Abbott R.D., Rodriguez B.L., Masaki K., Chen R., Sharp D.S., and Tall A.R. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res 45 (2004) 948-953
26. Hirano K., Yamashita S., Nakajima N., Arai T., Maruyama T., Yoshida Y., Ishigami M., Sakai N., Kameda-Takemura K., and Matsuzawa Y. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 17 (1997) 1053-1059
27. Moriyama Y., Okamura T., Inazu A., Doi M., Iso H., Mouri Y., Ishikawa Y., Suzuki H., Iida M., Koizumi J., Mabuchi H., and Komachi Y. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev Med 27 5 Pt 1 (1998) 659-667
28. Nicholls S.J., Tuzcu E.M., Brennan D.M., Tardif J.C., and Nissen S.E. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation). Circulation 118 (2008) 2506-2514
29. van Venrooij F.V., Stolk R.P., Banga J.D., Sijmonsma T.P., van Tol A., Erkelens D.W., Dallinga-Thie G.M., and DALI Study Group. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. Diabetes Care 26 (2003) 1216-1223